Condition
Membranous Nephropathy - PLA2R Induced clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Membranous Nephropathy - PLA2R Induced clinical trials that are recruiting, at sites in 2 countries (most in China (1), Netherlands (1)). By phase: Phase 1 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Obinutuzumab to reduce PLA2R antibodies in primary membranous nephropathy
We will try obinutuzumab to see if it quickly lowers anti‑PLA2R antibody levels in adults with high‑risk primary membranous nephropathy who still have heavy proteinuria despite ACEi/ARB treatment.
-
FKC288 treatment for autoimmune kidney diseases
This study is testing a new treatment called FKC288 to see if it can help people with tough autoimmune kidney diseases like lupus nephritis and ANCA-associated vasculitis.
Related topics
Quick answers
How many Membranous Nephropathy - PLA2R Induced clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.